We studied and optimised the properties of ultrathin superconducting niobium nitride films fabricated with a plasma-enhanced atomic layer deposition (PEALD) process. By adjusting process parameters, the chemical embedding of undesired oxygen into the films was minimised and a film structure consisting of mainly polycrystalline niobium nitride with a small fraction of amorphous niobium oxide and niobium oxo-nitrides were formed. For this composition a critical temperature of 13.8 K and critical current densities of 7 × 106 A cm–2 at 4.2 K were measured on 40 nm thick films. A fundamental correlation between these superconducting properties and the crystal lattice size of the cubic δ-niobium-nitride grains were found. Moreover, the film thickness variation between 40 and 2 nm exhibits a pronounced change of the electrical conductivity at room temperature and reveals a superconductor–insulator-transition in the vicinity of 3 nm film thickness at low temperatures. The thicker films with resistances up to 5 kΩ per square in the normal state turn to the superconducting one at low temperatures. The perfect thickness control and film homogeneity of the PEALD growth make such films extremely promising candidates for developing novel devices on the coherent quantum phase slip effect.
Superconducting NbN x thin films were deposited by plasma-enhanced atomic layer deposition (PEALD) using the metal organic precursor (tert-butylimido)-tris (diethylamino)-niobium (TBTDEN) and hydrogen plasma. The transition temperature T C and the resistivity of the NbN thin films were measured by four-point probe measurement. Their composition was analyzed by x-ray diffraction and Rutherford backscattering spectroscopy. The deposition process was optimized to obtain a low resistivity as well as a high superconducting transition temperature. A T C close to 10 K and a resistivity of 2.5 µ m as well as a critical current density of 8.9 × 10 5 A cm −2 were achieved. Originally, a high oxygen concentration was detected in the compound. By variation of the plasma parameters, the concentration could be reduced from 57 atom (at.)% to 11 at.%. Because of the excellent thickness control and conformality, such ALD films may be suited very well for applications in superconductor electronics and sensing devices.
Plasmon-based sensors are excellent tools for a label-free detection of small biomolecules. An interesting group of such sensors are plasmonic nanorulers that rely on the plasmon hybridization upon modification of their morphology to sense nanoscale distances. Sensor geometries based on the interaction of plasmons in a flat metallic layer together with metal nanoparticles inherit unique advantages but need a special optical excitation configuration that is not easy to miniaturize. Herein, we introduce the concept of nanoruler excitation by direct, electrically induced generation of surface plasmons based on the quantum shot noise of tunneling currents. An electron tunneling junction consisting of a metal-dielectric-semiconductor heterostructure is directly incorporated into the nanoruler basic geometry. With the application of voltage on this modified nanoruler, the plasmon modes are directly excited without any additional optical component as a light source. We demonstrate via several experiments that this electrically driven nanoruler possesses similar properties as an optically exited one and confirm its sensing capabilities by the detection of the binding of small biomolecules such as antibodies. This new sensing principle could open the way to a new platform of highly miniaturized, integrated plasmonic sensors compatible with monolithic integrated circuits.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.